Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y. Graham

Showing results (131-140 of 373) with videos related to

Pageof 38
Sort By:
Helicobacter|March 21, 2009
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradicationAbdallah Said Essa, Jennifer Rosenthal Kramer, David Y Graham, et al.
Cellular Microbiology|May 23, 2007
Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 productionIl Ju Choi, Saori Fujimoto, Kazuyoshi Yamauchi, et al.
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentationRatha-Korn Vilaichone, Varocha Mahachai, Chomsri Kositchaiwat, et al.
The American Journal of Gastroenterology|July 4, 2002
Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancerA Sepulveda, Leif E Peterson, Joseph Shelton, et al.
Journal of Clinical Microbiology|November 26, 2011
Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseasesMitsushige Sugimoto, Masahide Watada, Sung Woo Jung, et al.
Antibiotics (Basel, Switzerland)|October 14, 2020
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp TrialIra N Kalfus, David Y Graham, Dennis S Riff, et al.
Digestive Diseases and Sciences|March 6, 2008
Adherence, internalization, and persistence of Helicobacter pylori in hepatocytesKyoko Ito, Yoshio Yamaoka, Hiroyoshi Ota, et al.
The Journal of Infectious Diseases|May 10, 2002
Norwalk virus infection and disease is associated with ABO histo-blood group typeAnne M Hutson, Robert L Atmar, David Y Graham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 13, 2005
Visible small-intestinal mucosal injury in chronic NSAID usersDavid Y Graham, Antone R Opekun, Field F Willingham, et al.
The American Journal of Gastroenterology|December 1, 2007
Capsule endoscopy for screening for short-segment Barrett's esophagusWaqar A Qureshi, Justin Wu, Daniel Demarco, et al.
Pageof 38

Showing results (131-140 of 373) with videos related to

Sort By:
Pageof 38
Helicobacter|March 21, 2009
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradicationAbdallah Said Essa, Jennifer Rosenthal Kramer, David Y Graham, et al.
Cellular Microbiology|May 23, 2007
Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 productionIl Ju Choi, Saori Fujimoto, Kazuyoshi Yamauchi, et al.
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentationRatha-Korn Vilaichone, Varocha Mahachai, Chomsri Kositchaiwat, et al.
The American Journal of Gastroenterology|July 4, 2002
Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancerA Sepulveda, Leif E Peterson, Joseph Shelton, et al.
Journal of Clinical Microbiology|November 26, 2011
Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseasesMitsushige Sugimoto, Masahide Watada, Sung Woo Jung, et al.
Antibiotics (Basel, Switzerland)|October 14, 2020
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp TrialIra N Kalfus, David Y Graham, Dennis S Riff, et al.
Digestive Diseases and Sciences|March 6, 2008
Adherence, internalization, and persistence of Helicobacter pylori in hepatocytesKyoko Ito, Yoshio Yamaoka, Hiroyoshi Ota, et al.
The Journal of Infectious Diseases|May 10, 2002
Norwalk virus infection and disease is associated with ABO histo-blood group typeAnne M Hutson, Robert L Atmar, David Y Graham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 13, 2005
Visible small-intestinal mucosal injury in chronic NSAID usersDavid Y Graham, Antone R Opekun, Field F Willingham, et al.
The American Journal of Gastroenterology|December 1, 2007
Capsule endoscopy for screening for short-segment Barrett's esophagusWaqar A Qureshi, Justin Wu, Daniel Demarco, et al.
Pageof 38